Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker BGMS
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | FITTERS Diversified Berhad | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 12, 2026 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Yap Kim Choy | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| May 12, 2026 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Yap Kim Choy | 467,535 | 8.5% | SCHEDULE 13G/A ↗ |
| Mar 13, 2026 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Ong Yee Lung | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Mar 13, 2026 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Kua Khai Loon | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Nov 13, 2025 | SCHEDULE 13D/A (amended) | BGMS Bio Green Med Solution, Inc. | Doris Wong Sing Ee | 1.11M | 20.6% | SCHEDULE 13D/A ↗ |
| Nov 3, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Ong Yee Lung | 467,535 | 11.8% | SCHEDULE 13G/A ↗ |
| Oct 31, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Yap Kim Choy | 608,295 | 14.8% | SCHEDULE 13G/A ↗ |
| Oct 23, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | FITTERS Diversified Berhad | 279,248 | 8.0% | SCHEDULE 13G/A ↗ |
| Oct 14, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | FITTERS Diversified Berhad | 505,758 | 14.5% | SCHEDULE 13G/A ↗ |
| Oct 10, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Kua Khai Loon | 805,695 | 16.4% | SCHEDULE 13G/A ↗ |
| Sep 16, 2025 | SCHEDULE 13G | BGMS Bio Green Med Solution, Inc. | FITTERS Diversified Berhad | 699,158 | 20.0% | SCHEDULE 13G ↗ |
| Sep 2, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Ong Yee Lung | 872,000 | 20.8% | SCHEDULE 13G/A ↗ |
| Sep 2, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Kua Khai Loon | 872,000 | 20.8% | SCHEDULE 13G/A ↗ |
| Sep 2, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Yap Kim Choy | 872,000 | 20.8% | SCHEDULE 13G/A ↗ |
| Aug 18, 2025 | SCHEDULE 13G | BGMS Bio Green Med Solution, Inc. | Yap Kim Choy | 218,000 | 9.8% | SCHEDULE 13G ↗ |
| Aug 18, 2025 | SCHEDULE 13G | BGMS Bio Green Med Solution, Inc. | Ong Yee Lung | 218,000 | 9.8% | SCHEDULE 13G ↗ |
| Aug 18, 2025 | SCHEDULE 13G | BGMS Bio Green Med Solution, Inc. | Kua Khai Loon | 218,000 | 9.8% | SCHEDULE 13G ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Steven Boyd | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 14, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Armistice Capital, LLC | 0 | 0.0% | SCHEDULE 13G/A ↗ |
| Aug 8, 2025 | SCHEDULE 13D/A (amended) | BGMS Bio Green Med Solution, Inc. | David E. Lazar | 0 | 0.0% | SCHEDULE 13D/A ↗ |
| Aug 4, 2025 | SCHEDULE 13D/A (amended) | BGMS Bio Green Med Solution, Inc. | David E. Lazar | 129,629 | 8.2% | SCHEDULE 13D/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Steven Boyd | 24.84M | 9.2% | SCHEDULE 13G/A ↗ |
| May 15, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Armistice Capital, LLC | 24.84M | 9.2% | SCHEDULE 13G/A ↗ |
| Mar 4, 2025 | SCHEDULE 13D | BGMS Bio Green Med Solution, Inc. | Doris Wong Sing Ee | 194.63M | 70.0% | SCHEDULE 13D ↗ |
| Feb 28, 2025 | SCHEDULE 13D | BGMS Bio Green Med Solution, Inc. | David E. Lazar | 39.02M | 15.8% | SCHEDULE 13D ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Steven Boyd | 841,695 | 10.0% | SCHEDULE 13G/A ↗ |
| Feb 14, 2025 | SCHEDULE 13G/A (amended) | BGMS Bio Green Med Solution, Inc. | Armistice Capital, LLC | 841,695 | 10.0% | SCHEDULE 13G/A ↗ |
28 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 10:06 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances